Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Higher incidence of zinc and nickel hypersensitivity in patients with irritable bowel syndrome Original paper

Researched by:

  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

November 27, 2025

  • Metals
    Metals

    Heavy metals play a significant and multifaceted role in the pathogenicity of microbial species.

Researched by:

  • Dr. Umar ID
    Dr. Umar

    User avatarClinical Pharmacist and Clinical Pharmacy Master’s candidate focused on antibiotic stewardship, AI-driven pharmacy practice, and research that strengthens safe and effective medication use. Experience spans digital health research with Bloomsbury Health (London), pharmacovigilance in patient support programs, and behavioral approaches to mental health care. Published work includes studies on antibiotic use and awareness, AI applications in medicine, postpartum depression management, and patient safety reporting. Developer of an AI-based clinical decision support system designed to enhance antimicrobial stewardship and optimize therapeutic outcomes.

    Read More

Last Updated: 2024-10-18

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Karen Pendergrass

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

What was studied?

This study investigated the higher incidence of zinc and nickel hypersensitivity in patients with irritable bowel syndrome (IBS), directly exploring how metal-induced immune activation might contribute to low-grade mucosal inflammation. The focus keyphrase zinc and nickel hypersensitivity in IBS appears here because the researchers proposed that immune responses to trace metal ions released from dental materials could trigger or exacerbate IBS symptoms. The investigation assessed whether IBS patients exhibit elevated T-cell–mediated hypersensitivity to commonly used dental metals—zinc, nickel, gold, and palladium—using the drug-induced lymphocyte stimulation test (DLST). The study leveraged both quantitative stimulation indices and sensitization prevalence to determine whether metal hypersensitivity might serve as a microbial-relevant immune signature, potentially connecting environmental exposures to mucosal immune dysfunction in IBS.

Who was studied?

The study examined 147 Japanese adults diagnosed with IBS, classified by Rome IV criteria into IBS-D, IBS-C, IBS-M, and IBS-U subtypes. These individuals represented a clinically diverse group with chronic abdominal pain and altered bowel habits. A comparison group of 22 healthy controls with no IBS symptoms established baseline sensitization patterns. All participants underwent DLST testing to quantify lymphocyte activation in response to zinc, nickel, gold, and palladium. This population design enabled the researchers to distinguish disease-specific hypersensitivity patterns from background sensitization rates in the general population, illustrating how IBS patients may uniquely respond immunologically to metal exposures encountered through dental materials and dietary sources.

Most important findings

A strikingly higher proportion of IBS patients exhibited sensitization to at least one dental metal (56.5%) compared with healthy controls (31.8%), as shown in the sensitization bar chart. The most significant differences involved zinc and nickel. None of the healthy controls exhibited zinc hypersensitivity, whereas 36.4% of IBS patients did, with markedly elevated stimulation indices (mean SI, 352 vs. 119). Nickel hypersensitivity also differed significantly, affecting 39.6% of IBS patients versus 21.1% of controls, accompanied by higher mean SI values. Figures on page 3 visually depict these shifts with clearly elevated beeswarm distributions. No meaningful differences were observed for gold or palladium, and hypersensitivity rates did not vary across IBS subtypes. These results map closely to established immune pathways: zinc elicits CD8-dominant lichenoid reactions, while nickel promotes IL-17A-producing CD4+ T-cell expansion—both mechanisms implicated in mucosal immune dysregulation and gut–neuron signaling relevant to IBS.

Key implications

This study suggests that zinc and nickel hypersensitivity may contribute to the characteristic low-grade immune activation seen in a subset of IBS patients. Because many common foods are rich in these metals and dental alloys can release trace ions chronically, hypersensitive individuals may experience ongoing T-cell activation that amplifies visceral pain pathways and mucosal inflammation. The findings support further investigation of dietary metal load, dental materials, and immune profiling as potential components of microbiome-informed IBS management strategies. Although preliminary, the work highlights environmental–immune interactions that might modify the intestinal milieu, influence microbial composition, and shape patient-specific symptom patterns.

Citation

Kageyama Y, Aida K, Kawauchi K, Morimoto M, Akiyama T, Nakamura T. Higher incidence of zinc and nickel hypersensitivity in patients with irritable bowel syndrome. Immun Inflamm Dis. 2019;7(3):304-307. doi:10.1002/iid3.274 IID3-7-304

Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. Recent research has focused on the gut microbiota's role in IBS, aiming to identify specific microbial signatures associated with the condition.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.